Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users
Open Access
- 1 August 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 15 (suppl 3) , 120-134
Abstract
Unpredictable endometrial bleeding is the major side-effect of levonorgestrel-releasing s.c. implants (Norplant®), otherwise a method of choice for long-term contraception. The mechanisms responsible for bleeding are still unknown and no reliable treatment is available. Several matrix metalloproteinases (MMP) are expressed and activated in human endometrium only at menstruation and specific synthetic inhibitors of MMP fully prevent the tissue breakdown that occurs in menstrual-like endometrial explants. To investigate whether MMP are inappropriately expressed and activated in Norplant-treated endometria during bleeding episodes, volunteers were recruited to provide blood and endometrial biopsies at the start of bleeding episodes and during non-bleeding intervals. Whereas serum concentrations of levonorgestrel and sex hormones showed nochange at bleeding, except for a slight decrease of oestradiol concentration, the expression and activation of stromelysin-1 released by explants cultured for 1 day were consistently increased at the start of bleeding episodes. Furthermore, stromelysin-1 was immunolocalized in stromal cells within breakdown areas of several bleeding endometria, but not in non-bleeding endometria. These observations suggest that the expression and activation of stromelysin-1 participate in the initiation of bleeding episodes upon Norplant contraception. New strategies in the prevention and treatment of abnormal bleeding based nMMP control should be envisaged.Keywords
This publication has 28 references indexed in Scilit:
- Norplant® Consensus Statement and Background ReviewContraception, 1998
- Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant®)Contraception, 1997
- Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1α and its dual block by ovarian steroidsProceedings of the National Academy of Sciences, 1997
- Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesionsFertility and Sterility, 1997
- Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruationHuman Reproduction, 1996
- Matrix metalloproteinases in normal menstruationHuman Reproduction, 1996
- Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases.Proceedings of the National Academy of Sciences, 1996
- The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruationBiochemical Journal, 1995
- Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium.Proceedings of the National Academy of Sciences, 1994
- Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells.Proceedings of the National Academy of Sciences, 1987